| Income statement (USD) | Q1 2026 ended Mar 31, 2026 | Q4 2025 ended Dec 31, 2025 | Q3 2025 ended Sep 30, 2025 | Q2 2025 ended Jun 30, 2025 | Q1 2025 ended Mar 31, 2025 | Q4 2024 ended Dec 31, 2024 | Q3 2024 ended Sep 30, 2024 | Q2 2024 ended Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11.16B | 11.46B | 11.37B | 11.14B | 10.36B | 10.97B | 10.63B | 10.38B |
| Cost of revenue | 4.89B | 4.92B | 5.08B | 4.85B | 4.47B | 4.94B | 4.70B | 4.60B |
| Gross profit | 6.27B | 6.54B | 6.29B | 6.29B | 5.89B | 6.03B | 5.94B | 5.77B |
| Research and development | 767.00M | 735.00M | 766.00M | 725.00M | 716.00M | 749.00M | 713.00M | 698.00M |
| Selling, general and admin | 3.74B | 3.13B | 3.05B | 3.09B | 3.06B | 2.91B | 2.90B | 2.94B |
| Operating expenses | 9.82B | 9.21B | 9.31B | 9.09B | 8.66B | 9.06B | 8.78B | 8.71B |
| Operating income | 1.34B | 2.25B | 2.06B | 2.05B | 1.69B | 1.91B | 1.86B | 1.67B |
| EBITDA | 1.73B | 2.62B | 2.43B | 2.41B | 2.03B | 2.25B | 2.19B | 2.00B |
| Interest expense | 174.00M | 120.00M | 121.00M | 121.00M | 131.00M | 136.00M | 142.00M | 140.00M |
| Income before tax | 1.45B | 2.36B | 2.18B | 2.15B | 1.78B | 2.03B | 1.94B | 1.61B |
| Income tax | 372.00M | 582.00M | 536.00M | 371.00M | 453.00M | -7.20B | 294.00M | 305.00M |
| Net income | 1.08B | 1.78B | 1.64B | 1.78B | 1.32B | 9.23B | 1.65B | 1.30B |
| EPS | 0.62 | 1.01 | 0.94 | 1.02 | 0.76 | 5.28 | 0.94 | 0.74 |
| EPS (diluted) | 0.61 | 1.02 | 0.94 | 1.01 | 0.76 | 5.26 | 0.94 | 0.74 |
| Diluted shares | 1.75B | -1.16M | 1.75B | 1.75B | 1.75B | -1.43M | 1.75B | 1.75B |
| Dividends per share | 0.63 | 0.63 | 0.59 | 0.59 | 0.59 | 0.59 | 0.55 | 0.55 |
From Abbott Laboratories's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.